StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Outside U.S. volume growth impact YoY by Year

Outside U.S. volume growth impact YoY (%) (%)

Eli Lilly Outside U.S. volume growth impact YoY: 46.0% in FY2025, up 26.0 pts from a year earlier. That is the highest of the 9 years on record here.

Latest, FY2025
46.0%
Period ended Dec 31, 2025
Change on a year earlier
+26.0 pts
20.0% in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Where the FY2025 figure comes from

“|| Volume | 53 | % | 46 | % | 50 | %”

Source: Form 10-K FY2025 (filed 2026-02-12) ↗

Reported in Form 10-Q / 10-K MD&A & Form 8-K Q4 Releases.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOutside U.S. volume growth impact YoY (%) (%)Year on yearSource
FY2025Dec 31, 202546.0%+26.0 ptsForm 10-K FY2025 (filed 2026-02-12) ↗
FY2024Dec 31, 202420.0%-5.0 ptsForm 10-K FY2024 (filed 2025-02-19) ↗
FY2023Dec 31, 202325.0%+16.0 ptsForm 10-K FY2023 (filed 2024-02-21) ↗
FY2022Dec 31, 20229.0%-4.0 ptsForm 10-K FY2022 (filed 2023-02-22) ↗
FY2021Dec 31, 202113.0%0.0 ptsForm 10-K FY2021 (filed 2022-02-23) ↗
FY2020Dec 31, 202013.0%+3.0 ptsForm 10-K FY2020 (filed 2021-02-17) ↗
FY2019Dec 31, 201910.0%+3.0 ptsForm 10-K FY2019 (filed 2020-02-19) ↗
FY2018Dec 31, 20187.0%+2.0 ptsForm 10-K FY2018 (filed 2019-02-19) ↗
FY2017Dec 31, 20175.0%–Form 10-K FY2017 (filed 2018-02-20) ↗

Cite this data

StockData. (2026). Eli Lilly Outside U.S. volume growth impact YoY (%), annual FY2017–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/rev-growth-nonus-vol

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.